UBS raised its Teva price target to $48 after positive Phase 2a celiac disease results, while maintaining a Buy rating on the shares.
Author: Global Macro News Desk
Morgan Stanley upgraded Shell to Overweight and lifted its price target to $101.30, citing a longer production growth runway and potential dividend…
The Trade Desk plans to reduce its workforce by about 15% as part of a restructuring expected to produce up to $51 million in cash charges.
The U.S. trade deficit widened to $88.6 billion in July as imports rose and exports declined, according to government data.
Hillman said its Kanebridge acquisition creates its first U.S. master-distribution platform in industrial fasteners.
HF Foods completes Searay Foods acquisition, establishing its first international operating platform in Canada through a deal valued at about…
Samsung Life is reportedly considering a 15% stake in Principal Financial, but neither company has publicly confirmed a proposed transaction.
Early RASONQUE lung cancer data published in the NEJM showed a 42% response rate in a selected 38-patient subgroup, supporting an ongoing Phase…
Microsoft CEO Satya Nadella sold 85,485 shares worth approximately $42.9 million under a previously adopted Rule 10b5-1 trading plan.
Seaport Research began coverage of major U.S. energy stocks with Buy ratings on Occidental and Devon, while assigning a range of ratings across…
